Jeff Blankley MRPharmS Chair Birmingham Local Pharmaceutical Committee Value-based Decision Making in Community Pharmacy Funding Cuts and Quality Payments – Session 2 Jeff Blankley MRPharmS Chair Birmingham Local Pharmaceutical Committee Wolverhampton Local Pharmaceutical Committee Jan 2017 Intro Seen the style of slides before Thank to previous presenter For contractors there are decisions to be made as the business’s profit will come under pressure And this starts from Dec 16

Value-based Decision Making in Community Pharmacy Funding Cuts and Quality Payments – Session 2 Embed Sat’s video here Welcome Domestics Fire Toilets Breaks

Value-based Decision Making in Community Pharmacy Objectives of Session 2 Recap of cuts and changes to the funding structure Reminder of Gateway Criteria Role Clarification Provide information which enables compliance to claim Quality Payments in Safeguarding Dementia Friends HLP (requirements and training dates) Clinical Effectiveness Patient safety and service Sharing the plan for Feb – Apr 2017 Gather some feedback

Value-based Decision Making in Community Pharmacy My Expectations Pre –work completed (CPPE & Near Miss Log) You all receive a set of handouts Phones OFF We Keep to time Big room. A lot of people. ONE meeting That may mean your question is not asked Car park

Value-based Decision Making in Community Pharmacy Supporting YOU to be ready. Usual disclaimer/conditions apply Summary of Changes 2-year package -£113m in 16/17 (4 months) 17/18 squeeze to make up the lower reduction in 16/17 (late implementation) Single Activity Fee (SAF) £1.13 from Dec 16 increasing to £1.24 in April 17 Reduction in Establishment Payment (-20%) in Dec 16 and a further -20% from Apr 17 Introduction of Quality Payments from Apr 17 (£75m) (from existing funding) Gateway criteria to become eligible for Quality Payments Introduction of Pharmacy Access Scheme (PhAS) (4 in Birmingham, 1 in Wolverhampton) Introduction of ERMS linked to NHS 111 (Pilot) (£2m in 16/17) (WIGIG) (PhIF) Changes to market entry regulations. Mergers, PNAs Information is right at a certain point in time…….and new information is being received regularly

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Total of 100 points £64 per point = £6,400 per contract Size of the prize Birmingham = £1.862m Size of the prize Wolverhampton = £448k Could increase as additional allocation if less than 100% uptake To a max of £128 per point

Value-based Decision Making in Community Pharmacy Gateway Criteria for Quality Payments in 17/18 EPS is active and used NHS Choices is up to date and maintained Active NHS Mail address and active Delivery of at least ONE specified Advanced service

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Role LPC Committed to enabling 100% of contractors to claim maximum points Providing own sessions F2F and sequential written updates Providing online links and all F2F materials CPWM Website Signposting local alternatives Signposting essential allied events Role of the Contractors Committed to claiming maximum points Completing actions on time Could do with a link to CPWM and a screen shot of the site

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Domain Criteria Number of review points at which it can be claimed Points at any one review point Total points over the two review points Planned Support Patient Safety 80% of registered pharmacy professionals have achieved level 2 safeguarding status for children and vulnerable adults within the last two years Two 5 10 Session 2 Workforce 80% of all pharmacy staff working in patient facing roles are trained ‘Dementia Friends’ Session 2 and others

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Domain Criteria Number of review points at which it can be claimed Points at any one review point Total points over the two review points Planned Support Patient Safety Production of a written report that demonstrates evidence of analysis, learning and action taken in response to near misses and patient safety incidents, including implementation of national patient safety alerts and having shared learning One 20 Session 2 Patient Experience Results of patient experience survey from the last 12 months published on the pharmacy’s NHS Choices page 5

Session 2 plus additional specific dates Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Domain Criteria Number of review points at which it can be claimed Points at any one review point Total points over the two review points Planned Support Clinical Effectiveness Asthma patients dispensed more than 6 short acting bronchodilator inhalers without any corticosteroid inhaler within a 6-month period are referred to an appropriate health care professional for an asthma review Two 10 20 Session 2 Public Health Healthy Living Pharmacy level 1 (self-assessment) One Session 2 plus additional specific dates

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Agenda 10.00 – 12.30 Name Qualification CPPE Safeguarding & Dementia Friends 12.30 – 13.15 - Lunch 13.15 – 15.00 Leyla Hunnbeck NPA HLP & Clinical Effectiveness 15.00 – 15.15 - Tea 15.15 – 17.00 Surinderpal Virdee MRPharmS Clinical Governance Pharmacist Error, near misses & CPPQ

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 For CPPE Jeff Blankley MRPharmS Chair Birmingham Local Pharmaceutical Committee Wolverhampton Local Pharmaceutical Committee Jan 2017

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Insert CPPE slides

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Lunch Back at 13.15 pm prompt please

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Sat’s video again For 13.15

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 For Leyla Jeff Blankley MRPharmS Chair Birmingham Local Pharmaceutical Committee Wolverhampton Local Pharmaceutical Committee Jan 2017

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Insert NPA slides

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 For Surinderpal Jeff Blankley MRPharmS Chair Birmingham Local Pharmaceutical Committee Wolverhampton Local Pharmaceutical Committee Jan 2017

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Insert Surinder’s slides

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 Thanks to the presenters

Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 – Planned Events   Nov Dec Jan-17 Feb-17 Mar-17 Session 1 7th or 8th Session 2 8th All Day Session 3 tbc Session 4

Value-based Decision Making in Community Pharmacy Handout available To make sure the evidence is gathered BEFORE the event / end of year Agree the content

Quality Payment – Gateway Value-based Decision Making in Community Pharmacy February 2017 Venue tbc Evening Quality Payment – Gateway NHS Mail NHS Choices Qualification Points Domain Criteria Number of review points at which it can be claimed Points at any one review point Total points over the two review points   Digital Demonstration of having accessed the Summary Care Record and increase in access since the last review point Two 5 10 Session 3 NHS111 Directory of Services entry up to date at review point 2.5

Bringing It All Together PharmOutcomes Value-based Decision Making in Community Pharmacy March 2017 Venue tbc Evening Bringing It All Together PharmOutcomes

Value-based Decision Making in Community Pharmacy Close Request feedback form Don’t forget CPWM Website Thank you Safe journey home